Low birth weight is associated with maternal nevirapine based antiretroviral therapy in Abidjan, Côte d'Ivoire: the Ditrame Plus project and MTCT-Plus initiative (2001-2007) by unknown
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open AccessOral presentation
Low birth weight is associated with maternal nevirapine based 
antiretroviral therapy in Abidjan, Côte d'Ivoire: the Ditrame Plus 
project and MTCT-Plus initiative (2001-2007)
Patrick Coffie*1, Renaud Becquet2, Besigin Tonwe-Gold1, Apollinaire Horo1, 
Pety Touré3, Stéphane Blanche4, François Dabis2, Valeriane Leroy2 and 
Didier Ekouevi1
Address: 1ANRS DITRAME PLUS Project, PACCI Collaboration, Abidjan, Côte d'Ivoire, 2Unité INSERM 593, Institut de Santé Publique 
d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France, 3ACONDA, MTCT-Plus programme, Abidjan, Côte 
d'Ivoire and 4Service de Pédiatrie, Centre Hospitalier Universitaire Necker Enfants Malades, Paris, France
* Corresponding author    
Background
Pregnancy outcomes in women on antiretroviral treat-
ment (ART) in low resource-settings are unknown. We
investigate this issue within the Ditrame Plus project and
MTCT-Plus Initiative in Abidjan.
Methods
All HIV-infected pregnant women with at least one deliv-
ery and eligible for ART were included. Between March
2001 and July 2003 when ART was not available, they
received a short-course antiretroviral regimen (zidovu-
dine (ZDV) + single-dose of nevirapine (sdNVP) or ZDV +
lamivudine + sdNVP) (PMTCT Group) and between
August 2003 and August 2007, they received a NVP-based
ART therapy (ART Group). The following outcomes were
studied: low-birth weight (LBW) (<2500 g), stillbirth and
neonatal mortality. Women with multiple pregnancies
were excluded. Factors associated with LBW were analysed
using a logistic regression model.
Results
Overall, 326 HIV-1 infected women were included: 175 in
the PMTCT Group with a median CD4 count 177 cells/
mm3 and 151 initiated ART for at least 28 days before
delivery with median CD4 count 182 cells/mm3. Still
birth rate was 3.3% in the ART vs 2.9% in the PMTCT
group, (p=0.84). The rate of LBW was 22.3% in the ART
and 12.4% in the PMTCT group (p=0.02). The multivari-
ate regression model (n=309), ART was associated with
LBW when adjusting on the CD4 count, WHO staging,
maternal age and maternal body max index (ORa=2.53,
p=0.015). The survival at 12 month in HIV-uninfected
children was similar between the two groups (Log-Rank
test, p=0.78). Neither LBW (ORa=1.5, p=0.38) nor the
exposition to ART (ORa=1.1, p=0.85) were associated
with infant mortality.
Conclusions
ART initiated in pregnant women induced low birth
weight compared to newborn exposed to PMTCT regimen
despite a supplementation with multivitamin in all preg-
nant women. The proper effect of maternal HAART on
child survival needs to be assessed.
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